First precision medicine trial in cancer prevention identifies chemoprevention strategy
A team of scientists, led by researchers at University of California, San Diego Moores Cancer Center and The University of Texas MD Anderson Cancer Center, report that a genetic biomarker called loss of heterozygosity or ...
Nov 5, 2015
0
13